Cannabinoids

Artelo Biosciences Announces Publication of Study Results Comparing the Pharmacological Effects of Plant-Derived Versus Synthetic Cannabidiol in Human Cell Lines

Retrieved on: 
Wednesday, August 4, 2021
Cannabinoids, Drugs, Chemical compounds, Branches of biology, Cannabidiol, Endocannabinoid system, In vitro, CBD, Pharmacology

SOLANA BEACH, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, today announced the publication of study results in Medical Cannabis and Cannabinoids, a peer-reviewed journal. The study and related article, entitled “The Pharmacological Effects of Plant-Derived versus Synthetic Cannabidiol in Human Cell Lines,” compared the in vitro effects of purified natural and synthetic forms of Cannabidiol (CBD) to establish any pharmacological differences in human cell lines. The study found no in-vitro pharmacological difference in the antiproliferative, anti-inflammatory, or permeability effects of purified natural versus synthetic CBD.

Key Points: 
  • The study and related article, entitled The Pharmacological Effects of Plant-Derived versus Synthetic Cannabidiol in Human Cell Lines , compared the in vitro effects of purified natural and synthetic forms of Cannabidiol (CBD) to establish any pharmacological differences in human cell lines.
  • The study found no in-vitro pharmacological difference in the antiproliferative, anti-inflammatory, or permeability effects of purified natural versus synthetic CBD.
  • The company-sponsored study was led by Prof. Saoirse OSullivan, scientific advisor to Artelo Biosciences and former Professor of Pharmacology at the University of Nottingham, UK.
  • Artelo Biosciences, Inc.is a clinical stage biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics that target lipid signaling pathways, including the endocannabinoid system.

Sourcelight Combines CBD and Immunity Support in an All Natural, Sugar-Free Lollipop

Retrieved on: 
Wednesday, August 4, 2021
Cannabinoids, Candy, Lollipop, Entourage effect, CBD

Flight attendant shares her new CBD infused immunity support lollipops to a nation coming out of a pandemic.

Key Points: 
  • Flight attendant shares her new CBD infused immunity support lollipops to a nation coming out of a pandemic.
  • These whole plant compounds are responsible for the 'entourage effect' that enhances the benefits of CBD.
  • According to Sourceright Founder, Tamara Deer, "The idea for an immunity support lollipop came to me while recovering from a quadruple bypass.
  • Feel Well Lollys can be purchased at their website www.feelwelllollys.com and at the leading online CBD products retailer, www.CBD.co
    View original content to download multimedia: https://www.prnewswire.com/news-releases/sourcelight-combines-cbd-and-im...

Peels™ Debuts The Purest And Safest CBD On The Planet Made From Orange Peels, Guarantees Zero THC

Retrieved on: 
Tuesday, August 3, 2021
Drugs, Cannabinoids, Natural phenols, Resorcinols, Analgesics, Anticonvulsants, Cannabidiol, CBD

With both awards and certifications from Clean Label Project , Peels CBD Oil is the purest and safest CBD product on the market.

Key Points: 
  • With both awards and certifications from Clean Label Project , Peels CBD Oil is the purest and safest CBD product on the market.
  • "We're extremely proud of our CBD Oil and we know Peels is going to revolutionize the way people view and use CBD," continued Hetherington.
  • Peels offers the purest, safest CBD on the planet made from orange peels offering the highest quality, lowest risk cannabinoid product on the market.
  • Headquartered in Los Angeles, Peels is a data and science-driven CBD companydelivering better-for-you CBD wellness products.

Hemp Living Announces a Nostalgic Novelty Delta 8 Edible With a New Pop

Retrieved on: 
Friday, July 30, 2021
Cannabinoids, Drugs, Psychoactive drugs, Tetrahydrocannabinol, Neurochemistry, Delta-7-Tetrahydrocannabinol, Delta-4-Tetrahydrocannabinol

Each single-serve packet of Pot Rocks contains 100 mg of Delta 8 THC (

Key Points: 
  • Each single-serve packet of Pot Rocks contains 100 mg of Delta 8 THC (
  • According to Don Engelhardt, Director of Sales at Hemp Living, "The anticipation and interest in Pot Rocks is through the roof!
  • Their Delta 8, Delta 10, and CBD products ranging from Flower, Dabs, Cartridges, and Edibles, have made them a nationally-recognized brand in the Hemp Industry.
  • Hemp Living sources their hemp from local Wisconsin farms and conducts 3rd-party lab testing to ensure safe, high-quality Delta 8 products.

Allied Corp Completes Commercial CBD Shipments From Colombia Into Australia

Retrieved on: 
Thursday, July 29, 2021
Drugs, Cannabinoids, Analgesics, Anticonvulsants, Cannabidiol, Resorcinols, CBD

("Allied" or the Company) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address todays medical mental health issues is pleased to announce that it has completed its commercial shipments of cannabidiol (CBD) isolate from Colombia to Australia.

Key Points: 
  • ("Allied" or the Company) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address todays medical mental health issues is pleased to announce that it has completed its commercial shipments of cannabidiol (CBD) isolate from Colombia to Australia.
  • Allied has demonstrated its supply chain of producing in Colombia and exporting wholesale CBD products into international markets.
  • This shipment was produced from seed in Colombia at Allieds commercial production site, approved for export by the Colombian ministries of Justice, Health and Agriculture and then transported to Australia.
  • Allied has now shipped CBD to Peru, Australia, Europe and the United States.

Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21%

Retrieved on: 
Wednesday, July 28, 2021
Drugs, Organ systems, Psychoactive drugs, Cannabinoids, Resorcinols, Appetite stimulants, Entheogens, Euphoriants, Cannabidiol, Cannabis, Hemp

A report from Grand View said that the global cannabidiol market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028.

Key Points: 
  • A report from Grand View said that the global cannabidiol market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028.
  • Grand View added: "Furthermore, the use of hemp-derived CBD is increasing rapidly owing to its anti-inflammatory, anti-aging, and antioxidant properties.
  • This rapidly progressing transformation of cannabidiol from herbal preparations to prescription drugs is anticipated to boost the growth of the market.
  • Furthermore, growing awareness about the medical benefits of cannabidiol, including its healing properties, is anticipated to drive the product demand in the pharmaceutical industry."

NEOGEN Launches Reveal® Q+ for Δ9-THC in Hemp

Retrieved on: 
Wednesday, July 28, 2021
Drugs, Psychoactive drugs, Euphoriants, Appetite stimulants, Entheogens, Organ systems, Cannabis, Cannabinoids, Tetrahydrocannabinol, Hemp, Cannabidiol

NEOGEN's new Reveal Q+ for 9-THC can precisely detect and report THC levels between 0.1% and 1.6%, providing fast, reliable, and on-demand crop monitoring.

Key Points: 
  • NEOGEN's new Reveal Q+ for 9-THC can precisely detect and report THC levels between 0.1% and 1.6%, providing fast, reliable, and on-demand crop monitoring.
  • "The addition of the ability to test for 9-THC to our Reveal Q+ portfolio puts the power in the hands of hemp farmers," says John Adent, NEOGEN's President and CEO.
  • Hemp has various uses, including rope and textiles, feed and grain, and cannabidiol (CDB), commonly used in body care products and supplements.
  • NEOGEN Corporation develops and markets comprehensive solutions dedicated to food and animal safety.

Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 with a CAGR of 21%

Retrieved on: 
Wednesday, July 28, 2021
Drugs, Organ systems, Psychoactive drugs, Cannabinoids, Resorcinols, Appetite stimulants, Entheogens, Euphoriants, Cannabidiol, Cannabis, Hemp

PALM BEACH, Fla., July 28, 2021 /PRNewswire/ -- Cannabidiol derived from hemp is anticipated to witness rapid growth owing to increasing demand from the pharmaceutical sector and rising awareness among consumers regarding health. Increasing consumer disposable income along with the legalization of medicinal cannabis is anticipated to have a positive impact on the demand for cannabidiol in the pharmaceutical sector. Oils, tinctures, concentrate, capsules, topical solutions such as slaves, lip balms, lotions, and edibles such as baked goods, coffee, chocolates, gums, and candies are some of the CBD products which are in high demand. Due to its healing properties, the demand for cannabidiol (CBD) for health and wellness purposes is high, which is the major factor driving the market growth. In addition, the rising acceptance and use of products due to government approvals is a major factor expected to boost production for CBD-infused products.  A report from Grand View said that the global cannabidiol market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028.  Active Companies in the merchant industry include Grove, Inc. (NASDAQ: GRVI), Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY), Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED), Pressure BioSciences, Inc. (OTCQB: PBIO), cbdMD, Inc. (NYSE: YCBD).

Key Points: 
  • A report from Grand View said that the global cannabidiol market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.2% from 2021 to 2028.
  • Grand View added: "Furthermore, the use of hemp-derived CBD is increasing rapidly owing to its anti-inflammatory, anti-aging, and antioxidant properties.
  • This rapidly progressing transformation of cannabidiol from herbal preparations to prescription drugs is anticipated to boost the growth of the market.
  • Furthermore, growing awareness about the medical benefits of cannabidiol, including its healing properties, is anticipated to drive the product demand in the pharmaceutical industry."

CBD Global Sciences Management Cease Trade Order (MCTO) Revoked by the Alberta Securities Commission

Retrieved on: 
Tuesday, July 27, 2021
Drugs, Cannabinoids, Analgesics, Anticonvulsants, Cannabidiol, Resorcinols, CBD, Hemp

Denver, Colorado, July 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (CBD Global or the Company), acknowledges the Cease Trade Order (CTO) issued by the Alberta Securities Commission on 7/23/21.

Key Points: 
  • Denver, Colorado, July 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- CBD Global Sciences, Inc. (OTC: CBDNF) (CSE: CBDN) (Frankfurt:GS3), (CBD Global or the Company), acknowledges the Cease Trade Order (CTO) issued by the Alberta Securities Commission on 7/23/21.
  • Brad Wyatt, CEO of CBD Global Sciences, shared, This action to seek bankruptcy protection was complicated process but not insurmountable.
  • ABOUT CBD GLOBAL SCIENCES INC.
    CBD Global Sciences, Inc., is a hemp-based CBD producer and branding investment vehicle which currently owns two brands, branded under the name Aethics ( www.aethics.com ) and CANNAOIL ( www.cannaoilshop.com ), which include CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, Hydration products and Confectionary products.
  • CBD Global Sciences hemp-derived CBD extracts are sold through select distributors, brick and mortar retailers, and online.

CBD Product Sales Could Reach Nearly $17 Billion Dollars In The U.S. Alone By 2025

Retrieved on: 
Tuesday, July 27, 2021
Drugs, Anticonvulsants, Cannabidiol, Cannabinoids, Convenience store

A report from Statista added that In the United States, cannabidiol products generated sales of roughly five billion U.S. dollars in 2020.

Key Points: 
  • A report from Statista added that In the United States, cannabidiol products generated sales of roughly five billion U.S. dollars in 2020.
  • By 2025, CBD product salesare predicted to reach nearly 17 billion U.S. dollars in the United States.
  • With estimated sales of 730 million U.S. dollars, the state of California was the country's leading market for CBD products.
  • In American convenience stores, vitamins were the leading CBD segmentin terms of sales, generating over 20 million U.S. dollars in 2020.